Cargando…
How could preventive therapy affect the prevalence of drug resistance? Causes and consequences
Various forms of preventive and prophylactic antimicrobial therapies have been proposed to combat HIV (e.g. pre-exposure prophylaxis), tuberculosis (e.g. isoniazid preventive therapy) and malaria (e.g. intermittent preventive treatment). However, the potential population-level effects of preventativ...
Autores principales: | Kunkel, Amber, Colijn, Caroline, Lipsitch, Marc, Cohen, Ted |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424438/ https://www.ncbi.nlm.nih.gov/pubmed/25918446 http://dx.doi.org/10.1098/rstb.2014.0306 |
Ejemplares similares
-
What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?
por: Colijn, Caroline, et al.
Publicado: (2010) -
How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance
por: Colijn, Caroline, et al.
Publicado: (2015) -
Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis
por: Kunkel, Amber, et al.
Publicado: (2016) -
Host population structure and treatment frequency maintain balancing selection on drug resistance
por: Cobey, Sarah, et al.
Publicado: (2017) -
Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy
por: Colijn, Caroline, et al.
Publicado: (2011)